195 related articles for article (PubMed ID: 12020059)
1. Tomoxetine (Eli Lilly & Co).
Preti A
Curr Opin Investig Drugs; 2002 Feb; 3(2):272-7. PubMed ID: 12020059
[TBL] [Abstract][Full Text] [Related]
2. MethyPatch Noven.
Sane N; McGough JJ
Curr Opin Investig Drugs; 2002 Aug; 3(8):1222-4. PubMed ID: 12211419
[TBL] [Abstract][Full Text] [Related]
3. Ximelagatran (AstraZeneca).
Hopfner R
Curr Opin Investig Drugs; 2002 Feb; 3(2):246-51. PubMed ID: 12020054
[TBL] [Abstract][Full Text] [Related]
4. Valdecoxib (Pharmacia).
Gotta AW
Curr Opin Investig Drugs; 2002 Feb; 3(2):240-5. PubMed ID: 12020053
[TBL] [Abstract][Full Text] [Related]
5. Duloxetine Eli Lilly & Co.
Pitsikas N
Curr Opin Investig Drugs; 2000 Sep; 1(1):116-21. PubMed ID: 11249587
[TBL] [Abstract][Full Text] [Related]
6. Duloxetine Eli Lilly.
Anttila S; Leinonen E
Curr Opin Investig Drugs; 2002 Aug; 3(8):1217-21. PubMed ID: 12211418
[TBL] [Abstract][Full Text] [Related]
7. Dalbavancin (Biosearch Italia/Versicor).
Steiert M; Schmitz FJ
Curr Opin Investig Drugs; 2002 Feb; 3(2):229-33. PubMed ID: 12020051
[TBL] [Abstract][Full Text] [Related]
8. Pleconaril Sanofi Synthélabo/ViroPharma.
Billich A
Curr Opin Investig Drugs; 2000 Nov; 1(3):303-7. PubMed ID: 11249712
[TBL] [Abstract][Full Text] [Related]
9. Exubera. Inhale therapeutic systems.
Bindra S; Cefalu WT
Curr Opin Investig Drugs; 2002 May; 3(5):758-62. PubMed ID: 12090549
[TBL] [Abstract][Full Text] [Related]
10. Fulvestrant (AstraZeneca).
Johnston SR
Curr Opin Investig Drugs; 2002 Feb; 3(2):305-12. PubMed ID: 12020064
[TBL] [Abstract][Full Text] [Related]
11. Drug development process for a product with a primary pediatric indication.
Allen AJ; Michelson D
J Clin Psychiatry; 2002; 63 Suppl 12():44-9. PubMed ID: 12562061
[TBL] [Abstract][Full Text] [Related]
12. Atomoxetine in the treatment of attention deficit hyperactivity disorder.
Kratochvil CJ; Vaughan BS; Daughton JM; Mayfield-Jorgensen ML; Burke WJ
Expert Rev Neurother; 2004 Jul; 4(4):601-11. PubMed ID: 15853579
[TBL] [Abstract][Full Text] [Related]
13. Deramciclane (Egis).
Kõks S; Vasar E
Curr Opin Investig Drugs; 2002 Feb; 3(2):289-94. PubMed ID: 12020062
[TBL] [Abstract][Full Text] [Related]
14. Brasofensine NeuroSearch.
Yu P
Curr Opin Investig Drugs; 2000 Dec; 1(4):504-7. PubMed ID: 11249705
[TBL] [Abstract][Full Text] [Related]
15. DP-VPA D-Pharm.
Labiner DM
Curr Opin Investig Drugs; 2002 Jun; 3(6):921-3. PubMed ID: 12137414
[TBL] [Abstract][Full Text] [Related]
16. Gamma-Hydroxybutyrate (orphan medical).
Tunnicliff G; Raess BU
Curr Opin Investig Drugs; 2002 Feb; 3(2):278-83. PubMed ID: 12020060
[TBL] [Abstract][Full Text] [Related]
17. Repinotan Bayer.
Lutsep HL
Curr Opin Investig Drugs; 2002 Jun; 3(6):924-7. PubMed ID: 12137415
[TBL] [Abstract][Full Text] [Related]
18. Pexelizumab Alexion.
Whiss PA
Curr Opin Investig Drugs; 2002 Jun; 3(6):870-7. PubMed ID: 12137406
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder.
Spencer T; Biederman J; Wilens T; Prince J; Hatch M; Jones J; Harding M; Faraone SV; Seidman L
Am J Psychiatry; 1998 May; 155(5):693-5. PubMed ID: 9585725
[TBL] [Abstract][Full Text] [Related]
20. Abetimus (La Jolla pharmaceuticals).
Lorenz HM
Curr Opin Investig Drugs; 2002 Feb; 3(2):234-9. PubMed ID: 12020052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
